NCT02207465 2025-11-19
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Active not recruiting
Clinical Trials
1 trialsLocally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy × 130-nm albumin-bound paclitaxel × 1 year × Clear all